banner

Bexagliflozin

Product Name: Bexagliflozin
CAS NO.:1118567-05-7
Molecular formula:C24H29ClO7
EINECS:257-874-6
Synonyms:EGT1442
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 10g ,100g
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse
Send Inquiry Download
  • Product Description

Xi'an Faithful BioTech Co., Ltd: Your Trusted Bexagliflozin Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd supplies key intermediates and raw materials for SGLT2 inhibitor hypoglycemic drugs. Bexagliflozin is our flagship product. Since its establishment, we have always adhered to the service principles of flexible response, stable delivery, and strict confidentiality, serving high-quality customers in more than 20 regions around the world. The customer repurchase rate has remained stable at over 85% throughout the year.

Bexagliflozin Introduction

Bexagliflozin, as a highly selective inhibitor of sodium glucose cotransporter 2 (SGLT2), mainly exerts its hypoglycemic effect by inhibiting renal reabsorption of glucose and promoting urinary glucose excretion. It is used to control the blood sugar of adults with type 2 diabetes, as an auxiliary therapy besides diet and exercise. Our cooperative factory has introduced advanced production equipment, continuously improved processes, and ensured that products meet pharmacopoeia standards.

Specifications

Items

Specification

Results

Appearance

white to light yellow powder

light yellow powder

Water

0.5% max0.35%

Related substance

single impurity 0.5% max

total impurities 2.0% max

0.25%

0.5%

Assay 

99% Min99.35%

Conclusion:Complies with enterprise standard

Application area of Bexagliflozin

As an adjuvant therapy besides diet and exercise, it can improve the blood sugar control of adult patients with type 2 diabetes.

Clinical research shows that Bexaglinide can bring about moderate weight loss, which is beneficial to weight management of overweight or obese diabetes patients.

It has the function of blood pressure regulation and can reduce the blood pressure of patients with hypertension and diabetes.

Main Advantages

Clear target, high selectivity in inhibiting SGLT2, without affecting other sugar transporters such as SGLT1, low intestinal side effects.

Good hypoglycemic effect: Its hypoglycemic effect is independent, and the risk of hypoglycemia is low.

Multi metabolic effects: triple effects of lowering blood sugar, weight loss, and blood pressure, which can be said to be a multi effect drug that is convenient for patients to use.

If you need it ,you can click here

Why choose us

We ensure that the raw materials of Bexagliflozin and its intermediate 2-Cyclopropoxyethanol are produced strictly in accordance with a high standard internal control system, support third-party review, and implement full process monitoring of key impurities. At the same time, we have stable production capacity and flexible stocking mechanism, which can cover multi-stage needs from research and development to commercialization, eliminating the risk of supply interruption. In addition, we adhere to service boundaries, focus on raw material quality control and delivery execution, ensure transparent and predictable quality, delivery time, and terms, and strictly keep customer information confidential, winning trust with professionalism and professionalism.

Quality Control

Bexagliflozin

R&D Results

Bexagliflozin

Packaging and Transportation

Bexagliflozin

Bexagliflozin

After-Sales Service

Bexagliflozin

Qualification Certification

Bexagliflozin

Exhibition

Bexagliflozin

FAQ

Q1:Is Bexagliflozin effective the same as Dapagliflozin and Empagliflozin?

A1:They are all SGLT2 inhibitors with similar mechanisms of action. Besagliflozin, newly launched in 2023, not only has hypoglycemic effects, but also has antihypertensive and weight loss effects.

Q2:Can type 1 diabetes patients use Bexagliflozin?

A2:Not recommended. Bexagliflozin is mainly used for type 2 diabetes. For type 1 patients, it will significantly increase the risk of diabetes ketoacidosis (DKA).

Q3:What are the most common adverse reactions?

A3:Adverse reactions with an incidence rate exceeding 5% include female genital fungal infections, urinary tract infections, and increased urination.

Contact US

Professional supply of Bexagliflozin raw materials, welcome to inquiry sales1@faithfulbio.com.

Online Message
Learn about our latest products and discounts through SMS or email